The U.S. Food and Drug Administration has given the green light to the marketing of a new generic version of mifepristone, the pill used in the majority of abortions in the United States, a decision that provoked fury from conservative circles on Thursday.
"This is a stain on the Trump presidency," an "inconceivable decision," Kristan Hawkins, president of the powerful anti-abortion group Students for Life Action, said in a statement.
This decision was, however, a routine procedure, as the Food and Drug Administration (FDA) had already approved another generic version of mifepristone.
Used for 25 years in the United States, this pill is prescribed in combination with another pill in medical abortions, but also to treat certain miscarriages.
The arrival of this new generic, produced by the Evita solutions laboratory, has nevertheless sparked outrage among several conservative elected officials and anti-abortion associations, who have been pressuring the federal government since the return of Donald Trump to obtain new access restrictions.
"This is a total betrayal of the movement (...) that elected President Trump," accused former Vice President Mike Pence on X, a devout Christian who had enabled the Republican to gain the favor of the religious right during his first presidential campaign.
This announcement comes as the Trump administration has promised to reassess the safety of mifepristone, a prospect that deeply worries abortion rights advocates.
They fear a tightening of access to abortion under this new term of the Republican, who boasts of having enabled the cancellation in 2022 of the federal guarantee of abortion by appointing conservative judges to the Supreme Court.
The scientific community considers this pill to be safe.
English 
French